Trials / Completed
CompletedNCT00524836
Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis
A Study Evaluating the Efficacy and Safety of 5 mg Levocetirizine Oral Tablets, Once Daily Versus 10 mg Loratadine Oral Tablets, Once Daily for the Treatment of Perennial Allergic Rhinitis.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 71 (actual)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | levocetirizine dihydrochloride |
Timeline
- Start date
- 2003-09-01
- Primary completion
- 2004-02-01
- Completion
- 2004-02-01
- First posted
- 2007-09-05
- Last updated
- 2013-12-16
Source: ClinicalTrials.gov record NCT00524836. Inclusion in this directory is not an endorsement.